Prophylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexate
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06146-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Qinxia Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Methotrexate, Trimethoprim, Sulfamethoxazole Drug Combination, Central Nervous System Neoplasms, Lymphoma. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission Special Project for Clinical Research in the Health Care Industry, Clinical Pharmacy Research Fund Project of the Clinical Pharmacy Branch of the Chinese Medical Association of the China International Medical Exchange Foundati…, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
- Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
- Department of Hematology, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
- Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China. zwu14@fudan.edu.cn.
Förderung
- Shanghai Municipal Health Commission Special Project for Clinical Research in the Health Care Industry
- Clinical Pharmacy Research Fund Project of the Clinical Pharmacy Branch of the Chinese Medical Association of the China International Medical Exchange Foundati…
- National Natural Science Foundation of China
- Shanghai "Rising Stars of Medical Talent" Youth Development Program Clinical Pharmacist Program
- Shanghai “Rising Stars of Medical Talent” Youth Development Program Clinical Pharmacist Program
Zitieren
APA
Xu, Q., Li, Z., Ding, T., Qiu, X., & Wu, Z. (2024). Prophylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexate. Annals of Hematology. https://doi.org/10.1007/s00277-024-06146-4
Vancouver
Xu Q, Li Z, Ding T, Qiu X, Wu Z. Prophylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexate. Annals of Hematology. 2024. doi:10.1007/s00277-024-06146-4
BibTeX
@article{Xu2024,
author = {Xu, Qinxia and Li, Ziran and Ding, Tianling and Qiu, Xiaoyan and Wu, Zhuo},
title = {Prophylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexate},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06146-4}
}
EUVIMED